|
"huang d c l"的相關文件
顯示項目 21-23 / 23 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2014-05-13 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H |
| 國立臺灣大學 |
2014 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H; 林家齊; 楊志新; 盧彥伸; 鄭安理; 徐志宏; 葉坤輝 |
| 國立成功大學 |
2013-09 |
Efficacy and safety of nintedanib vs sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC): A randomised Phase II trial
|
Yen, C.;Kim, T. Y.;Feng, Y. H.;Chao, Y.;Lin, D. Y.;Studeny, M.;Hocke, J.;Huang, D. C. L.;Ryoo, B. Y.;Cheng, A. L. |
顯示項目 21-23 / 23 (共1頁)
1
每頁顯示[10|25|50]項目
|
